The Genomics of Prostate Cancer: emerging understanding with technologic advances.

Rubin, Mark Andrew; Demichelis, Francesca (2018). The Genomics of Prostate Cancer: emerging understanding with technologic advances. Modern pathology, 31(S1), S1-11. Nature Publishing Group 10.1038/modpathol.2017.166

[img] Text
modpathol2017166.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (222kB) | Request a copy

With the advent of next-generation sequencing technologies and large whole-exome and genome studies in prostate and other cancers, our understanding of the landscape of genomic alterations has dramatically been refined. In additional to well-known alterations in genomic regions involving 8p, 8q, 10q23, common ETS translocations and androgen receptor amplifications, newer technology have uncovered recurrent mutations in SPOP, FOXA1, MED12, IDH and complex large scale genomic alterations (eg, chromoplexy). This review surveys the enhanced landscape of genomic alterations in clinically localized and advanced prostate cancer.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie

UniBE Contributor:

Rubin, Mark Andrew

Subjects:

500 Science
500 Science > 570 Life sciences; biology

ISSN:

0893-3952

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Marla Rittiner

Date Deposited:

08 Mar 2018 15:16

Last Modified:

28 Oct 2019 22:36

Publisher DOI:

10.1038/modpathol.2017.166

PubMed ID:

29297493

BORIS DOI:

10.7892/boris.110878

URI:

https://boris.unibe.ch/id/eprint/110878

Actions (login required)

Edit item Edit item
Provide Feedback